The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

This past year, the role of ctDNA testing has expanded to guide treatment decisions for providers and patients with cancer.

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

Hispanic/Latinx communities are the fastest-growing population in the US. In 2023,the US Census Bureau reported that the ...

FDA gives nod of approval to first derived mesenchymal stromal cell therapy for the treatment of pediatric patients with ...

Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative ...

Pharmacologic strategies may be able to prevent abnormal uterine bleeding in patients undergoing stem cell transplant.

Nurses play an important role in the administration of biosimilars and the education of patients receiving them.

Novel Drug Combo Is Promising for PD-L1-Resistant Solid Cancers ...

Treatment with subcutaneous daratumumab significantly improved progression-free survival in patients with intermediate- or ...